Nir Goldenberg
Mayo Clinic Ventures
Director, Technology Development

Nir joined Business Development in 2022. He is a member of the Mayo Clinic Ventures Executive Committee and leads the Technology Development function, responsible for facilitating the development and commercialization of Mayo Clinic technologies by collaborating with Mayo Clinic staff, external companies, entrepreneurs, and investors.

Prior to joining Mayo, Nir was CEO of Trendlines Innovation Labs (TIL), which focuses on in-house and collaborative invention and investment opportunities in the life science space. Prior to his appointment as CEO, he served as TIL’s VP Business Development. Before Trendlines, he was Director of Commercial Development for Europe at INSIGHTEC Ltd., a global MR-guided focused ultrasound surgery company.

Nir holds a BSc in engineering from La Sapienza University of Rome.

Nir Goldenberg